Arena Pharmaceuticals, Inc. (ARNA)
(Delayed Data from NSDQ)
$47.60 USD
+1.62 (3.52%)
Updated May 3, 2019 04:00 PM ET
After-Market: $47.68 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ARNA]
Reports for Purchase
Showing records 161 - 177 ( 177 total )
Industry: Medical - Biomedical and Genetics
Potential Delay To Resubmitting Complete Response Letter Reply
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
Continues Lorcaserin Preclinical Studies Through 2011
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY.
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY.
Provider: RODMAN & RENSHAW, CO.